Texas girl hospitalized after J&J shot with related signs as blood clot instances By Reuters
© Reuters. FILE PHOTO: Boxes of Johnson & Johnson’s COVID-19 vaccine are seen at McKesson Corporation in Shepherdsville
From Kanishka Singh
(Reuters) – A woman in Texas who received the COVID-19 vaccine from Johnson & Johnson (NYSE 🙂 was hospitalized after showing symptoms similar to those of six people recently admitted to the United States had suffered blood clots, Texas health agency spokesman said Thursday.
The incident comes as advisors to the U.S. Centers for Disease Control and Prevention (CDC) meet on Friday to see if it is safe to resume injections of J & J’s COVID-19 vaccine, and senior US health officials prepare for the go-ahead.
U.S. health officials last week recommended discontinuing use of the J&J single vaccine because of rare cases of blood clots in six of the roughly 7 million people who received the shot in the country.
A health ministry spokesman said the CDC informed the state agency on Wednesday of the incident and did not provide additional information to protect the patient’s privacy.
“The patient is an adult woman who was hospitalized after receiving the J&J vaccine. Symptoms appear to be consistent with the six cases reported elsewhere last week,” the spokesman said in an email sent statement.
The Austin American-Statesman newspaper, which first reported the incident, said federal agencies are investigating the case.
“It is important to remember that something that is reported does not necessarily mean that it was caused by or related to the vaccine,” Imelda Garcia, deputy commissioner for the Infectious Diseases Division of the Texas Department of Health, was quoted as saying in the newspaper.
The European Medicines Agency (EMA) announced Tuesday that it had found a possible link between J & J’s vaccine and rare blood clotting problems in adults given doses in the United States. However, the benefits of the single-dose shot outweigh the risks.
Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.
Fusion Media or any person involved with Fusion Media assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.